Meltable Polycarbonate Polymersomes as Photoresponsive Micro‐Analgesia Pumps for Concurrent Tumor Therapy and Pain Relief

J Jiajia Tan (State Key Laboratory of Precision and Intelligent Chemistry, Department of Polymer Science and Engineering, School of Chemistry and Materials Science) J Jiqian Zhang M Minglong Chen (State Key Laboratory of Precision and Intelligent Chemistry, Department of Polymer Science and Engineering) J Jie Cen (State Key Laboratory of Precision and Intelligent Chemistry, Department of Polymer Science and Engineering) W Wenli Wang C Chengying You (Department of Pharmacy, The First Affiliated Hospital of the University of Science and Technology of China, and State Key Laboratory of Precision and Intelligent Chemistry) X Xianglong Hu (Department of Pharmacy The First Affiliated Hospital of the University of Science and Technology of China and State Key Laboratory of Precision and Intelligent Chemistry University of Science and Technology of China Hefei Anhui 230026 China) J Jinming Hu S Shiyong Liu (State Key Laboratory of Precision and Intelligent Chemistry, Department of Polymer Science and Engineering, School of Chemistry and Materials Science)

Abstract

Abstract Over 75% of patients with advanced‐stage tumors experience severe cancer‐associated pain, yet current opioid‐based therapies are limited by dose‐dependent toxicity, adverse side effects, and poor delivery control. Here, we present a light‐responsive meltable polycarbonate polymersome (MPP) micro‐analgesia pump, self‐assembled from Nile blue‐labeled polycarbonate block copolymers encapsulating tetrodotoxin (TTX), a non‐opioid analgesic. The MPPs effectively suppress spontaneous TTX leakage under dark conditions, thereby minimizing off‐target toxicity, while enabling on‐demand release upon red light irradiation. This release is driven by localized photothermal heating of aggregated Nile blue moieties, which induces melting of the polycarbonate bilayer membrane. In addition, the photoresponsive system integrates photothermal and photodynamic effects to inhibit tumor growth while simultaneously alleviating tumor‐induced pain. Overall, this strategy provides a promising non‐opioid approach for concurrent management of cancer pain and tumor progression.

Article Details

Volume / Issue Vol. 65, Issue 5
Published January 28, 2026
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (9)

J

Jiajia Tan

State Key Laboratory of Precision and Intelligent Chemistry, Department of Polymer Science and Engineering, School of Chemistry and Materials Science

J

Jiqian Zhang

M

Minglong Chen

State Key Laboratory of Precision and Intelligent Chemistry, Department of Polymer Science and Engineering

J

Jie Cen

State Key Laboratory of Precision and Intelligent Chemistry, Department of Polymer Science and Engineering

W

Wenli Wang

C

Chengying You

Department of Pharmacy, The First Affiliated Hospital of the University of Science and Technology of China, and State Key Laboratory of Precision and Intelligent Chemistry

X

Xianglong Hu

Department of Pharmacy The First Affiliated Hospital of the University of Science and Technology of China and State Key Laboratory of Precision and Intelligent Chemistry University of Science and Technology of China Hefei Anhui 230026 China

J

Jinming Hu

S

Shiyong Liu

State Key Laboratory of Precision and Intelligent Chemistry, Department of Polymer Science and Engineering, School of Chemistry and Materials Science